NKE
36
2
USB
50
3
IPG
43
3
HPQ
55
3
ROP
44
6
HPE
48
2
MET
58
2
HBI
53
4
TAP
57
6
BK
60
2
KEY
24
2
NEM
30
2
IP
53
3
IR
46
3
GRMN
53
3
CTAS
36
8
EXPD
29
2
BMY
40
-5
SLG
37
6
URBN
67
3
NKE
36
2
USB
50
3
IPG
43
3
HPQ
55
3
ROP
44
6
HPE
48
2
MET
58
2
HBI
53
4
TAP
57
6
BK
60
2
KEY
24
2
NEM
30
2
IP
53
3
IR
46
3
GRMN
53
3
CTAS
36
8
EXPD
29
2
BMY
40
-5
SLG
37
6
URBN
67
3
Financhill
Back

Range Nuclear Renaissance Index ETF Vs. Viking Therapeutics Industry Stock Comparison

Sell
11

NUKZ
Range Nuclear Renaissance Index ETF

Last Price:
$41.74
Seasonality Move:
--
Sell
22

VKTX
Viking Therapeutics

Last Price:
$42.31
Seasonality Move:
40.87%
Sell
11
Range Nuclear Renaissance Index ETF (NUKZ) is a Sell

Is Range Nuclear Renaissance Index ETF a Buy, Sell or Hold?

  • The current Range Nuclear Renaissance Index ETF [NUKZ] share price is $41.66. The Score for NUKZ is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
  • NUKZ is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
22
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $42.25. The Score for VKTX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NUKZ Stock Price Chart

What is Range Nuclear Renaissance Index ETF's stock price today?

  • The Range Nuclear Renaissance Index ETF share price today is $41.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NUKZ is experiencing slight buying pressure.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $42.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.

NUKZ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.58 Sell
Relative Strength Index (14 RSI): 40.95 Sell
Chaikin Money Flow: 11910 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.42 - 45.9) Sell
Bollinger Bands (100): (33.2 - 43.94) Buy

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.14 Sell
Relative Strength Index (14 RSI): 33.93 Sell
Chaikin Money Flow: -7091274 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.45 - 53.01) Sell
Bollinger Bands (100): (51.47 - 67.23) Sell

NUKZ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.23 Sell
20-day SMA: 44.08 Sell
50-day SMA: 43.41 Sell
200-day SMA: 35.48 Buy
8-day EMA: 42.2 Sell
20-day EMA: 43.19 Sell
50-day EMA: 42.4 Sell
200-day EMA: 19.72 Buy

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.01 Sell
20-day SMA: 48.87 Sell
50-day SMA: 57.76 Sell
200-day SMA: 61.76 Sell
8-day EMA: 44.4 Sell
20-day EMA: 48.41 Sell
50-day EMA: 54.21 Sell
200-day EMA: 54.36 Sell

Range Nuclear Renaissance Index ETF Earnings Growth & NUKZ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.47 per share.

Range Nuclear Renaissance Index ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):